ID: ALA4175176

Max Phase: Preclinical

Molecular Formula: C22H21N3O5

Molecular Weight: 407.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC[C@H]1O[C@@H](c2nc(-c3ccc4cc5ccccc5cc4c3)n[nH]2)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C22H21N3O5/c26-10-16-17(27)18(28)19(29)20(30-16)22-23-21(24-25-22)14-6-5-13-7-11-3-1-2-4-12(11)8-15(13)9-14/h1-9,16-20,26-29H,10H2,(H,23,24,25)/t16-,17-,18+,19-,20-/m1/s1

Standard InChI Key:  PREPOTGODMDPMY-OUUBHVDSSA-N

Associated Targets(Human)

Liver glycogen phosphorylase 1040 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glycogen phosphorylase, muscle form 1331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 407.43Molecular Weight (Monoisotopic): 407.1481AlogP: 1.29#Rotatable Bonds: 3
Polar Surface Area: 131.72Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.48CX Basic pKa: 0.50CX LogP: 1.45CX LogD: 1.45
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.32Np Likeness Score: 0.26

References

1. Kun S, Begum J, Kyriakis E, Stamati ECV, Barkas TA, Szennyes E, Bokor É, Szabó KE, Stravodimos GA, Sipos Á, Docsa T, Gergely P, Moffatt C, Patraskaki MS, Kokolaki MC, Gkerdi A, Skamnaki VT, Leonidas DD, Somsák L, Hayes JM..  (2018)  A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.,  147  [PMID:29453094] [10.1016/j.ejmech.2018.01.095]

Source